Senior investor and corporate director with a track record of scaling growth-stage companies and advising venture and private-equity managers. Elizabeth C. Carr combines operational leadership in finance and strategy with board governance experience across healthcare and technology portfolios. She focuses on scalable business models, capital efficiency and exit readiness, and is active in direct investments, follow-on financings and board-level performance improvement. Known for disciplined valuation approach and hands-on portfolio company support.
Senior investor and corporate director with a track record of scaling growth-stage companies and advising venture and private-equity managers. Elizabeth C. Carr combines operational leadership in finance and strategy with board governance experience across healthcare and technology portfolios. She focuses on scalable business models, capital efficiency and exit readiness, and is active in direct investments, follow-on financings and board-level performance improvement. Known for disciplined valuation approach and hands-on portfolio company support.
Combines operational finance and board experience to favor capital-efficient, scalable growth-stage companies in healthcare and technology. Prioritizes rigorous valuation and milestone-driven capital deployment, blending seed-to-growth direct investments with selective follow-ons to preserve ownership and optionality. Emphasizes measurable KPIs, governance upgrades, and exit-readiness through strategic M&A or IPO paths. Risk discipline centers on downside protection, capital efficiency, and active, hands-on portfolio engagement.
Combines operational finance and board experience to favor capital-efficient, scalable growth-stage companies in healthcare and technology. Prioritizes rigorous valuation and milestone-driven capital deployment, blending seed-to-growth direct investments with selective follow-ons to preserve ownership and optionality. Emphasizes measurable KPIs, governance upgrades, and exit-readiness through strategic M&A or IPO paths. Risk discipline centers on downside protection, capital efficiency, and active, hands-on portfolio engagement.
| Trades 867 | Longs Won 613/867 70% | Profit Factor 7.97 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $704,234.26 |
| Average Win $174,195.61 | Best Trade (Aug 14) $13.55M | Sharpe Ratio -9.9 |
| Average Loss -$52,771.36 | Worst Trade (Mar 30) -$4.33M | Z-Score 11.43 (100%) |
| Commissions $0 | Avg. Trade Length 10m 2w 1d | Expectancy $107,636.16 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,850 | 7,965 | 7,080 | 6,195 | 5,310 | 4,425 | 3,540 | 2,655 | 1,770 | 885 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAAU Goldman Sachs Physical Gold ETF | 276,529 | $11.64M | $11.04M | - | -$594,661.66 | -5.11% | -1.456% |
AAPL Apple Inc. | 75,516 | $18.91M | $23.33M | - | $4.42M | 23.35% | -7.354% |
ABBV AbbVie Inc. | 2,971 | $530,205.03 | $745,542.74 | - | $215,337.71 | 40.61% | -2.513% |
ABT Abbott Laboratories | 2,687 | $304,609.84 | $284,015.9 | - | -$20,593.94 | -6.76% | +0.085% |
ACVF American Conservative Values ETF | 4,415 | $193,142.59 | $238,414.41 | - | $45,271.82 | 23.44% | +0.549% |
AMAT Applied Materials, Inc. | 849 | $337,128.05 | $431,011.84 | - | $93,883.79 | 27.85% | +1.176% |
AMD Advanced Micro Devices, Inc. | 1,008 | $215,553.3 | $479,959.19 | - | $264,405.89 | 122.66% | -1.904% |
AMGN Amgen Inc. | 1,173 | $306,282.43 | $451,792.68 | - | $145,510.25 | 47.51% | -0.64% |
AMZN Amazon.com Inc | 14,045 | $3.08M | $3.81M | - | $731,657.47 | 23.73% | +15.321% |
ASML ASML Holding N.V. New York Registry Shares | 159 | $210,303 | $259,011 | - | $48,708 | 23.16% | -1.359% |
AVGO Broadcom Inc. | 977 | $286,615.98 | $380,326.56 | - | $93,710.58 | 32.7% | +0.371% |
BA Boeing Company | 3,426 | $636,182.46 | $740,495.64 | - | $104,313.18 | 16.4% | -2.155% |
BAC Bank of America Corporation | 11,644 | $555,955.35 | $721,345.8 | - | $165,390.45 | 29.75% | +0.356% |
BAR GraniteShares Gold Trust | 12,000 | $310,680 | $478,200 | - | $167,520 | 53.92% | -1.508% |
BOXX Alpha Architect 1-3 Month Boxx Fund | 7,759 | $858,852.17 | $913,234.3 | - | $54,382.13 | 6.33% | +0.06% |
| BPRE BPRE | 28,566 | $428,388.52 | $428,490 | - | $101.48 | 0.02% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 14,051 | $6.58M | $7.19M | - | $606,984.73 | 9.22% | +0.365% |
BUXX Strive Enhanced Income Short Duration Fund | 25,125 | $509,520.86 | $507,776.25 | - | -$1,744.61 | -0.34% | +0.05% |
CAOS Alpha Architect Tail Risk ETF | 30,201 | $2.66M | $2.73M | - | $73,244.04 | 2.75% | -0.055% |
CAT Caterpillar Inc. | 343 | $365,221 | $279,479.83 | - | -$85,741.17 | -23.48% | +0.701% |